Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Schechter

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Design and early clinical evaluation of selective inhibitors of monoamine oxidaseM G Palfreyman, I A McDonald, P Bey, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1985
Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialS Van Nieuwenhove, P J Schechter, J Declercq, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxiaA M Bonnet, M Esteguy, G Tell, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Pharmacokinetics of vigabatrin: implications of creatinine clearanceK D Haegele, N D Huebert, M Ebel, et al.
Neurology|January 1, 1984
Gamma-vinyl GABA treatment of Huntington's diseaseG Scigliano, P Giovannini, F Girotti, et al.
Journal of Neurochemistry|November 1, 1987
2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acidK D Haegele, J J Schwartz, J Schoun, et al.
L'Encephale|January 1, 1983
[Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia]P A Lambert, J P Chabannnes, P Cantiniaux, et al.
Antisense Research and Development|January 1, 1994
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkeyW M Galbraith, W C Hobson, P C Giclas, et al.
Biological Trace Element Research|November 23, 2013
Tissue-and metal-specific effects of thiolacrylic acids in ratsE Giroux, P J Lachmann, H G Petering, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG)J A Gastaut, G Tell, P J Schechter, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Design and early clinical evaluation of selective inhibitors of monoamine oxidaseM G Palfreyman, I A McDonald, P Bey, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1985
Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialS Van Nieuwenhove, P J Schechter, J Declercq, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxiaA M Bonnet, M Esteguy, G Tell, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Pharmacokinetics of vigabatrin: implications of creatinine clearanceK D Haegele, N D Huebert, M Ebel, et al.
Neurology|January 1, 1984
Gamma-vinyl GABA treatment of Huntington's diseaseG Scigliano, P Giovannini, F Girotti, et al.
Journal of Neurochemistry|November 1, 1987
2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acidK D Haegele, J J Schwartz, J Schoun, et al.
L'Encephale|January 1, 1983
[Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia]P A Lambert, J P Chabannnes, P Cantiniaux, et al.
Antisense Research and Development|January 1, 1994
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkeyW M Galbraith, W C Hobson, P C Giclas, et al.
Biological Trace Element Research|November 23, 2013
Tissue-and metal-specific effects of thiolacrylic acids in ratsE Giroux, P J Lachmann, H G Petering, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG)J A Gastaut, G Tell, P J Schechter, et al.
Pageof 7